Research progress on ferroptosis in drug-induced kidney injury
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-13146-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 10.11.2026. Verfasst von Ye Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Key Laboratory of Hereditary Rare Diseases of Health Commission of Henan Pr…. Hauptthemen laut MEDLINE: Ferroptosis, Acute Kidney Injury. Die Arbeit nennt 121 Literaturangaben. Gefördert von: General Program of Henan Natural Science Foundation, the Key Scientific Research Project Plan of Higher Education Institutions in Henan Provinc, the Henan Medical Science and Technology Research Project.
Abstract (Originalsprache)
Ferroptosis is a novel form of programmed cell death that has garnered increasing attention in recent years in the study of drug-induced kidney injury, where it plays a critical role in the onset and progression of the disease. This review systematically summarizes the core mechanisms and regulatory pathways of ferroptosis in kidney injury, as well as the crosstalk between ferroptosis and other forms of programmed cell death. It further discusses how microbial-derived drugs, traditional Chinese medicines, and their active monomers induce renal ferroptosis through their respective core targets, thereby mediating drug-induced kidney injury. By synthesizing existing evidence, this paper clarifies the common patterns and key targets by which various drugs induce kidney injury via the ferroptosis pathway. It provides a theoretical foundation for drug safety evaluation, clinical medication risk early warning and targeted renal protection strategies, and also sheds new light on the exploration of combined medication schemes, indirect toxic mechanisms and individualized toxicity detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Key Laboratory of Hereditary Rare Diseases of Health Commission of Henan Province, Henan Key Laboratory of Rare Diseases, Endocrinology and Metab…
- Department of Pharmacy, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, China.
- School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
Förderung
- General Program of Henan Natural Science Foundation
- the Key Scientific Research Project Plan of Higher Education Institutions in Henan Provinc
- the Henan Medical Science and Technology Research Project
Zitieren
APA
Sun, Y., Shang, Z., Cao, A., Zhao, C., Yang, B., Fan, C., Ji, Q., Chen, Z., Liu, C., & Li, X. (2026). Research progress on ferroptosis in drug-induced kidney injury. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13146-2
Vancouver
Sun Y, Shang Z, Cao A, Zhao C, Yang B, Fan C, et al. Research progress on ferroptosis in drug-induced kidney injury. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13146-2
BibTeX
@article{Sun2026,
author = {Sun, Ye and Shang, Ziyi and Cao, Aijia and Zhao, Chengcheng and Yang, Bowen and Fan, Chunyang and Ji, Qijia and Chen, Zilong and Liu, Chuanxin and Li, Xuejiao},
title = {Research progress on ferroptosis in drug-induced kidney injury},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-13146-2}
}
EUVIMED